期刊文献+

单纯疱疹病毒胸苷激酶基因工程化细胞和更昔洛韦系统的急慢性毒性 被引量:1

Toxicity studies of retroviralmediated herpes simplex virus thymidine kinase gene transfer and ganciclovir administration
下载PDF
导出
摘要 目的:探讨单纯疱疹病毒Ⅰ型胸苷激酶基因工程化细胞(pLTKcSN/VPC)和更昔洛韦(GCV)系统的动物体内急、慢性毒性。方法:将pLTKcSN/VPC和(或)以β-半乳糖苷酶基因为报告基因的PA317细胞悬液注入小鼠、大鼠和灵长类动物体内,7d后部分动物再全身应用GCV。分批处死动物,观察pLTKcSN/VPC和GCV系统在不同种属动物的体内急、慢性毒性。采用PCR和原位杂交方法直接检测胸苷激酶基因在动物脑和全身各脏器内的整合及表达情况。结合原位杂交和X-gal染色结果,判断注射细胞在动物脑内的存活时间。结果:pLTKcSN/VPC和GCV系统对动物的心、肝、肺和肾有一定的急性损害作用。该细胞在大鼠和猴脑内的存活时间为3周。 Objective: To study the toxicities of the retroviralvector producer cells of herpes simplex virus thymidine kinase gene(pLTKcSN/VPC) and the ganciclovir(GCV) system in mice, rats and primates. Methods: pLTKcSN/VPC and/or the cell suspension of PA317 cells modified by the βgal reporter gene were injected into the animal bodies, and 7 d later, some of the animals were given GCV. The animals were then sacrificed as scheduled, and the acute and long term toxicities of this treatment system were evaluated through histological studies and direct detection of the transduction and expression of the thymidine kinase (TK) gene in animal brain and other organs. The survival interval of the xenogenic cells in rat and monkey brain was determined by the Xgal staining and the  in situ  hybridization of the TK gene in brain. Results: The pLTKcSN/VPC and GCV system had certain acute side effects on heart, liver, lung and kidney, but no long term toxicities could be detected. The survival time of pLTKcSN/VPC in the brain of rats and primates was 3 weeks. Conclusion: The pLTKcSN/VPC and GCV system has slight toxicities when applied in vivo. 
出处 《第二军医大学学报》 CAS CSCD 北大核心 1998年第2期137-139,共3页 Academic Journal of Second Military Medical University
基金 国家"863"计划生物领域"九五"重点课题
关键词 神经胶质瘤 基因治疗 单纯疱疹病毒 更昔洛韦 glioma gene therapy herpes simplex virus ganciclovir
  • 相关文献

参考文献2

二级参考文献1

  • 1Chen C Y,Hum Gene Ther,1995年,6卷,11期,1467页

共引文献18

同被引文献8

  • 1许秀兰,张晓鹏,郭忠,胡加飞,朱诚,顾健人.疱疹病毒I型中国株胸苷激酶基因治疗脑瘤的临床前研究[J].中华医学杂志,1997,77(1):35-38. 被引量:3
  • 2Okada H,Giezeman-Smits KM,Tahara H,et al.Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine [J].Gene Ther,1999,6:219-226.
  • 3Dvais FG,Freels S,Gru J,et al.Survival rates in patients with primary malignant brain tumor stratified by patient age and tumor histological type:an analysis based on surveillance,epidemiology,and end results(SEER) data,1973-1991 [J].J Neurosurg,1998,88:1-10.
  • 4Oldfield EH,Ram Z,Culver KW,et al.Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir [J].Hum Gene Ther,1993,4:39-69.
  • 5Packer RJ,Raffe C,Villablanca JG.Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration [J].J Neurosurg,2000,92:249-254.
  • 6Shand N,Weber F,Mariani L,et al.A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir [J].Hum Gene Ther,1999,10:2325-2335.
  • 7Dewey RA,Morrissey G,Cowsill CM,et al.Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy:implications for clinical trials [J].Nat Med,1999,5:1256-1263.
  • 8王伟民,郭忠,蔡如珏,张光霁,许秀兰,朱诚,顾健人.逆转录病毒载体介导中国单疱病毒TK基因转导脑胶质瘤细胞[J].中华神经外科杂志,1997,13(5):271-273. 被引量:4

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部